Literature DB >> 19304673

Inflammation imaging in atherosclerosis.

James H F Rudd1, Fabien Hyafil, Zahi A Fayad.   

Abstract

Inflammation is important at many stages of atherosclerotic plaque development. We highlight several imaging modalities that can quantify the degree of plaque inflammation noninvasively. Imaging of this type might allow testing of novel antiatherosclerosis drugs, identification of patients at risk of plaque rupture, and deeper insight into the biology of the disease. The imaging modalities are discussed in relation to their potential use in these areas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19304673      PMCID: PMC2836586          DOI: 10.1161/ATVBAHA.108.165563

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  95 in total

1.  Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages.

Authors:  Rikin A Trivedi; Chinthake Mallawarachi; Jean-Marie U-King-Im; Martin J Graves; Jo Horsley; Martin J Goddard; Andrew Brown; Liqun Wang; Peter J Kirkpatrick; John Brown; Jonathan H Gillard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

2.  Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation.

Authors:  Takayoshi Ishimori; Tsuneo Saga; Marcelo Mamede; Hisataka Kobayashi; Tatsuya Higashi; Yuji Nakamoto; Noriko Sato; Junji Konishi
Journal:  J Nucl Med       Date:  2002-05       Impact factor: 10.057

3.  Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.

Authors:  Matthias Nahrendorf; Farouc A Jaffer; Kimberly A Kelly; David E Sosnovik; Elena Aikawa; Peter Libby; Ralph Weissleder
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

Review 4.  Characterization of atherosclerotic plaques by magnetic resonance imaging.

Authors:  Z A Fayad; V Fuster
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

5.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

Review 6.  Radionuclide imaging: a molecular key to the atherosclerotic plaque.

Authors:  Harald F Langer; Roland Haubner; Bernd J Pichler; Meinrad Gawaz
Journal:  J Am Coll Cardiol       Date:  2008-07-01       Impact factor: 24.094

7.  Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.

Authors:  David Izquierdo-Garcia; John R Davies; Martin J Graves; James H F Rudd; Jonathan H Gillard; Peter L Weissberg; Tim D Fryer; Elizabeth A Warburton
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

8.  Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro.

Authors:  Jan Thiess Deichen; Olaf Prante; Michaela Gack; Kristin Schmiedehausen; Torsten Kuwert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11-05       Impact factor: 9.236

9.  In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI.

Authors:  Rikin A Trivedi; Jean-Marie U-King-Im; Martin J Graves; Justin J Cross; Jo Horsley; Martin J Goddard; Jeremy N Skepper; George Quartey; Elizabeth Warburton; Ilse Joubert; Liqun Wang; Peter J Kirkpatrick; John Brown; Jonathan H Gillard
Journal:  Stroke       Date:  2004-05-27       Impact factor: 7.914

10.  Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events.

Authors:  Benoît Paulmier; Michèle Duet; Raphaël Khayat; Nadia Pierquet-Ghazzar; Jean-Pierre Laissy; Christophe Maunoury; Florent Hugonnet; Elisabeth Sauvaget; Ludovic Trinquart; Marc Faraggi
Journal:  J Nucl Cardiol       Date:  2008 Mar-Apr       Impact factor: 3.872

View more
  53 in total

1.  Human ferritin cages for imaging vascular macrophages.

Authors:  Masahiro Terashima; Masaki Uchida; Hisanori Kosuge; Philip S Tsao; Mark J Young; Steven M Conolly; Trevor Douglas; Michael V McConnell
Journal:  Biomaterials       Date:  2010-11-11       Impact factor: 12.479

2.  High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.

Authors:  Fabien Hyafil; Andreas Schindler; Dominik Sepp; Tilman Obenhuber; Anna Bayer-Karpinska; Tobias Boeckh-Behrens; Sabine Höhn; Marcus Hacker; Stephan G Nekolla; Axel Rominger; Martin Dichgans; Markus Schwaiger; Tobias Saam; Holger Poppert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-03       Impact factor: 9.236

Review 3.  Quantum dot-based nanoprobes for in vivo targeted imaging.

Authors:  Y Zhu; H Hong; Z P Xu; Z Li; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

4.  Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques.

Authors:  Yuji Kuge; Nozomi Takai; Yuki Ogawa; Takashi Temma; Yan Zhao; Kantaro Nishigori; Seigo Ishino; Junko Kamihashi; Yasushi Kiyono; Masashi Shiomi; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-13       Impact factor: 9.236

5.  Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging.

Authors:  Denis B Buxton; Melissa Antman; Narasimhan Danthi; Vasken Dilsizian; Zahi A Fayad; Mario J Garcia; Michael R Jaff; Michael Klimas; Peter Libby; Matthias Nahrendorf; Albert J Sinusas; Samuel A Wickline; Joseph C Wu; Robert O Bonow; Ralph Weissleder
Journal:  Circulation       Date:  2011-05-17       Impact factor: 29.690

6.  Collagenase-Cleavable Peptide Amphiphile Micelles as a Novel Theranostic Strategy in Atherosclerosis.

Authors:  Deborah D Chin; Christopher Poon; Noah Trac; Jonathan Wang; Jackson Cook; Johan Joo; Zhangjingyi Jiang; Naomi Sulit Sta Maria; Russell E Jacobs; Eun Ji Chung
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

7.  Identification of inflamed atherosclerotic lesions in vivo using PET-CT.

Authors:  Mateja Kaja Jezovnik; Nina Zidar; Luka Lezaic; Borut Gersak; Pavel Poredos
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

8.  Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.

Authors:  Nimali P Withana; Toshinobu Saito; Xiaowei Ma; Megan Garland; Changhao Liu; Hisanori Kosuge; Myriam Amsallem; Martijn Verdoes; Leslie O Ofori; Michael Fischbein; Mamoru Arakawa; Zhen Cheng; Michael V McConnell; Matthew Bogyo
Journal:  J Nucl Med       Date:  2016-05-19       Impact factor: 10.057

9.  Will molecular optical imaging have clinically important roles in stroke management, and how?

Authors:  Dong Kun Lee; Matthias Nahrendorf; Dawid Schellingerhout; Dong-Eog Kim
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

10.  FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.

Authors:  John R Davies; David Izquierdo-Garcia; James H F Rudd; Nichola Figg; Hugh K Richards; Joseph L E Bird; Franklin I Aigbirhio; Anthony P Davenport; Peter L Weissberg; Tim D Fryer; Elizabeth A Warburton
Journal:  Int J Cardiovasc Imaging       Date:  2009-09-22       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.